Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 August, 2017 15:17 IST
Glenmark Pharma gets USFDA nod for Fingolimod capsules
Source: IRIS | 20 Mar, 2017, 10.45AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Fingolimod Capsules, 0.5 Mg, the generic version of Gilenya Capsules of Novartis Pharmaceuticals Corp.

According to IMS Health sales data for the 12 month period ending January 2017, Gilenya Capsules, 0.5 mg achieved annual sales of approximately USD 2.03 billion.
 
Glenmark's current portfolio consists of 112 products authorized for distribution in the U.S. marketplace and approximately 65 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark (Q,N,C,F)* continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

All brand names and trademarks are the property of their respective owners.

Shares of the company declined Rs 11.4, or 1.29%, to trade at Rs 874.95. The total volume of shares traded was 12,617 at the BSE (10.38 a.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Telecommunications sector to generate 30 lakh jobs by 2018: Assocham-KPMG - 18-Aug-2017 12:20
Vishal Sikka resigns as MD & CEO of Infosys - 18-Aug-2017 12:12
HDFC Bank revises interest rates on saving bank accounts - 18-Aug-2017 11:42
Power Grid to invest Rs 19.31 bn for power transmission related project - 18-Aug-2017 11:30
Infosys in association with ATP unveils new PlayerZone - 18-Aug-2017 11:26
Raymond acquires Ansel's stake in JV entity 'JK Ansell' - 18-Aug-2017 10:24
Piramal Enterprises' arm acquires 100% stake in Context Matters - 17-Aug-2017 10:03
Karnataka Bank ventures into social media presence - 17-Aug-2017 10:00
Majesco expands strategic partnership with tier one insurer - 17-Aug-2017 09:54
L&T to divest entire stake in L&T Cutting Tools for Rs 1.74 bn - 17-Aug-2017 09:46
EESL and IOCL, BPCL & HPCL sign MOUs for distribution of energy efficient appliances - 17-Aug-2017 08:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer